I am a breastfeeding mother and i want to know if it is safe to use 2-(Acetolyloxy)-N-(5-nitro-2-thiazolyl)benzamide? Is 2-(Acetolyloxy)-N-(5-nitro-2-thiazolyl)benzamide safe for nursing mother and child? Does 2-(Acetolyloxy)-N-(5-nitro-2-thiazolyl)benzamide extracts into breast milk? Does 2-(Acetolyloxy)-N-(5-nitro-2-thiazolyl)benzamide has any long term or short term side effects on infants? Can 2-(Acetolyloxy)-N-(5-nitro-2-thiazolyl)benzamide influence milk supply or can 2-(Acetolyloxy)-N-(5-nitro-2-thiazolyl)benzamide decrease milk supply in lactating mothers?
- DrLact safety Score for 2-(Acetolyloxy)-N-(5-nitro-2-thiazolyl)benzamide is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of 2-(Acetolyloxy)-N-(5-nitro-2-thiazolyl)benzamide is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that 2-(Acetolyloxy)-N-(5-nitro-2-thiazolyl)benzamide does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of 2-(Acetolyloxy)-N-(5-nitro-2-thiazolyl)benzamide safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Anti-protozoan drug which is used for treatment of Cryptosporidiosis, Giardia lamblia infection, Intestinal Amoeba Disease, Blastocystis, Leishmaniasis of skin and Microsporidiosis. Excreted into breast milk in non-significant clinical amount. The use is authorized for children older than 1 year. Likely side-effects are mild and infrequent (abdominal pain, diarrhea, vomiting)
Limited information indicates that a maternal dose of 500 mg of 2-(Acetolyloxy)-N-(5-nitro-2-thiazolyl)benzamide produces low levels of an active metabolite, tizoxanide, in breastmilk and would not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months. But until more data become available, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.